Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Nu Skin Enterprises, Inc (NYSE: NUS) closed the day trading at $11.15 up 5.39% from the previous closing price of $10.58. In other words, the price has increased by $5.39 from its previous closing price. On the day, 1.0 million shares were traded. NUS stock price reached its highest trading level at $11.15 during the session, while it also had its lowest trading level at $10.69.
Ratios:
For a better understanding of NUS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.41. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 2.01. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 31, 2023, Downgraded its rating to Hold and sets its target price to $39 from $43 previously.
BofA Securities Upgraded its Underperform to Neutral on October 02, 2020, whereas the target price for the stock was revised from $54 to $58.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’25 when WOODBURY EDWINA D sold 4,532 shares for $8.44 per share. The transaction valued at 38,250 led to the insider holds 42,947 shares of the business.
Battle Emma S. sold 4,532 shares of NUS for $38,250 on Jun 02 ’25. The Director now owns 31,006 shares after completing the transaction at $8.44 per share. On Jun 02 ’25, another insider, WOODBURY EDWINA D, who serves as the Director of the company, bought 4,532 shares for $8.44 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUS now has a Market Capitalization of 551899328 and an Enterprise Value of 625005504. As of this moment, Nu’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.56, and their Forward P/E ratio for the next fiscal year is 7.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.34 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at 0.384 whereas that against EBITDA is 3.985.
Stock Price History:
The Beta on a monthly basis for NUS is 0.86, which has changed by 0.16145837 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, NUS has reached a high of $10.64, while it has fallen to a 52-week low of $5.32. The 50-Day Moving Average of the stock is 31.19%, while the 200-Day Moving Average is calculated to be 51.04%.
Shares Statistics:
Over the past 3-months, NUS traded about 549.31K shares per day on average, while over the past 10 days, NUS traded about 700690 shares per day. A total of 49.50M shares are outstanding, with a floating share count of 47.54M. Insiders hold about 3.96% of the company’s shares, while institutions hold 75.71% stake in the company. Shares short for NUS as of 1753920000 were 1854881 with a Short Ratio of 3.38, compared to 1751241600 on 2165242. Therefore, it implies a Short% of Shares Outstanding of 1854881 and a Short% of Float of 3.8.
Dividends & Splits
NUS’s forward annual dividend rate is 0.24, up from 0.24 a year ago. Against a Trailing Annual Dividend Yield of 0.02268431The stock’s 5-year Average Dividend Yield is 4.61.
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of Nu Skin Enterprises, Inc (NUS) in the stock market.The consensus estimate for the next quarter is $0.33, with high estimates of $0.33 and low estimates of $0.33.
Analysts are recommending an EPS of between $1.26 and $1.26 for the fiscal current year, implying an average EPS of $1.26. EPS for the following year is $1.56, with 1.0 analysts recommending between $1.56 and $1.56.
Revenue Estimates
1 analysts predict $374.2M in revenue for the current quarter. It ranges from a high estimate of $374.2M to a low estimate of $374.2M. As of the current estimate, Nu Skin Enterprises, Inc’s year-ago sales were $430.14MFor the next quarter, 1 analysts are estimating revenue of $392.1M. There is a high estimate of $392.1M for the next quarter, whereas the lowest estimate is $392.1M.
A total of 1 analysts have provided revenue estimates for NUS’s current fiscal year. The highest revenue estimate was $1.52B, while the lowest revenue estimate was $1.52B, resulting in an average revenue estimate of $1.52B. In the same quarter a year ago, actual revenue was $1.73BBased on 1 analysts’ estimates, the company’s revenue will be $1.53B in the next fiscal year. The high estimate is $1.53B and the low estimate is $1.53B.
